on BioVersys AG
BioVersys Sets March 26 for Full-Year 2024 Financial Results Release
On March 14, 2025, BioVersys AG, a biopharmaceutical company based in Basel, Switzerland, announced it will release its Full-Year 2024 financial results on March 26, 2025. The results will be published at 7:00 AM CET, followed by a conference call and webcast at 2:00 PM CET.
The company focuses on developing novel antibacterial products targeting multidrug-resistant bacteria. The leadership team will provide insights into BioVersys' financial performance, strategic plans, and therapeutic pipeline during the event.
Interested parties can register for the conference call to receive dial-in details. The webcast will also be available online. Attendees are advised to mute their browser audio during the session.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all BioVersys AG news